|
|
| The Pricing and Reimbursement Environment for Neurology Drugs |
|
| Table of Contents Published: 2009/08 Published by: Decision Resources, Inc. |
| Neurological disorders will impose a growing social and fi nancial burden on the major pharmaceutical markets as the elderly population in these countries increases steadily. Governments and other payers recognize the pressing need to tackle these disease ... |
| World Generics Market 2009-2024 |
|
| Table of Contents Published: 2009/08 Published by: Visiongain |
| The generic pharmaceuticals sector has been expanding strongly in recent years as the need for cheaper medicines worldwide has increased. The next five years from 2009 will see more leading drugs going off patent, thus increasing opportunities for generic ... |
| Wound Treatments in Chile |
|
| Table of Contents Published: 2009/08 Published by: Euromonitor International |
| Euromonitor International' s Wound Treatments in Child report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. ... |
| Wound Treatments in Morocco |
|
| Table of Contents Published: 2009/08 Published by: Euromonitor International |
| Euromonitor International' s Wound Treatments in Morocco report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| Amgen Inc.: PharmaVitae Profile |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Amgen in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal ... |
| Analgesics in Slovakia |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| Euromonitor International' s Analgesics in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| Antihormonal Therapies Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| Antihormonal cancer therapies are a class of drugs used predominantly in the treatment of breast cancer and prostate cancer. The high incidence of these tumor types translates into a significant commercial potential for drug developers. Collectively, the ... |
| Attention-Deficit Hyperactivity Disorder Market Forecast |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| Driven primarily by continued uptake of Shire' s market leading ADHD drug, Adderall XR (amphetamine extended release), seven major market ADHD revenues grew strongly at a compound annual growth rate (200408) of 13.5% to reach almost $4.4 billion in 2008. ... |
| Autoimmune Disease Therapeutics |
|
| Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc. |
| This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Billion by the following therapeutic class - Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Crohn' s Disease (Biologics only), and Others. The report provides sepa ... |
| Bariatric (Obesity) Surgical Devices |
|
| Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc. |
| This report analyzes the US and European markets for Bariatric (Obesity) Surgical Devices in Millions of US$. The US market for Bariatric Surgical Devices is analyzed by the following segments: Gastric Bypass Devices, and Gastric Banding Devices. ... |
| Bayer Schering Pharma AG: PharmaVitae Profile |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Bayer Schering in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sa ... |
| Biosimilars and Biobetters: Positioning for a New Market |
|
| Table of Contents Published: 2009/07 Published by: Biophoenix Limited |
| This new and timely report analyzes the emerging market for first- and second-generation biosimilars. The market can best be understood in the context of the established $110 billion biologics business, which is therefore comprehensively reviewed. Current ... |
| Brachytherapy |
|
| Table of Contents Published: 2009/07 Published by: Global Industry Analysts, Inc. |
| This report analyzes the Global Market for Brachytherapy in Millions of US$. The eBrachytherapy' market is analyzed in terms of the following product segments: Implantable Prostate Seeds Brachytherapy, and Post-Operative Brachytherapy. Annual forecasts a ... |
| Building an Effective Regulatory Relationship with the FDA |
|
| Table of Contents Published: 2009/07 Published by: Best Practices, LLC |
| This report delivers benchmarks and insights that identify approaches for understanding and effectively interacting with the FDA. The research is based on detailed survey data from Regulatory Affairs executives and managers from 15 top pharmaceutical comp ... |
| China Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/07 Published by: Business Monitor International |
| For the Q309 update of BMI's China Pharmaceuticals & Healthcare report, we have maintained our topline
forecast for medicine expenditure in the world's most populous country, as no new sales figures have
emerged and the country's macroeconomic projectio ... |
| Clinical Trials: World Market 2009-2024 |
|
| Table of Contents Published: 2009/07 Published by: Visiongain |
| The market for clinical trials has been expanding rapidly in recent years, with impressive revenue growth and important trends. One regional market expanded by 65% in 2008. From the perspectives of various pharma stakeholders, the expanding clinical resea ... |
| Competitor Analysis: HDAC Inhibitors |
|
| Table of Contents Published: 2009/07 Published by: La Merie |
| The present Competitive Intelligence Report about HDAC Inhibitors provides a competitor evaluation in the field of novel molecular entities inhibiting histone deacetylase for treatment of cancer and other diseases as of July 2009. ... |
| Competitor Analysis: PI3K-AKT-mTOR Inhibitors |
|
| Published: 2009/07 Published by: La Merie |
| The report includes a compilation of current active projects in research and development of PI3K-AKT-mTOR inhibitors in oncology and other indications. ... |
| Digestive Remedies in Slovakia |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| Euromonitor International' s Digestive Remedies in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| Drug and Device Combination (2009 - 2014) |
|
| Table of Contents Published: 2009/07 Published by: Markets and Markets |
| Drug device combination is defined as the combination of drugs and medical devices that can be chemically or physically united or co-packaged as separate, cross labeled products. The commercialization cycle from R&D to product shows the immense potential ... |
| Drug Delivery Markets: Oral Delivery |
|
| Table of Contents Published: 2009/07 Published by: Kalorama Information |
| Since our last edition of this report in 2007, the oral drug delivery market is the largest segment of the drug delivery market, and there' s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend th ... |
| Eli Lilly & Co.: PharmaVitae Profile |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Eli Lilly in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales f ... |
| Eye Care in Slovakia |
|
| Table of Contents Published: 2009/07 Published by: Euromonitor International |
| Euromonitor International' s Eye Care in Slovakia report offers a comprehensive guide to the size and shape of the market at a national level. ... |
| F. Hoffmann-La Roche Ltd.: PharmaVitae Profile |
|
| Table of Contents Published: 2009/07 Published by: Datamonitor |
| This analysis examines the historical and forecast performance for Roche in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sal ... |
| Generic Drugs: The Global Market |
|
| Table of Contents Published: 2009/07 Published by: BCC Research |
| The aim of this report is to provide detailed market, technology, and industry analyses to help readers quantify and qualify the market for prescription generic drugs. Important trends are identified and sales forecasts by product categories and major cou ... |
|
|
Top
View Cart
